Insulin antibodies with pulmonary delivery of insulin

Diabetes Technology and Therapeutics

Volumn 9, Issue SUPPL. 1, 2007, Pages

  Fineberg, S Edwin ^a,b,d   Kawabata, Thomas T ^c   Krasner, Alan S ^c   Fineberg, Naomi S ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d Pfizer Global Research and Development ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE INSULIN; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN G; INSULIN; INSULIN ANTIBODY; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT; PIG INSULIN;

ANTIBODY RESPONSE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ANTIGENICITY; DRUG DELIVERY SYSTEM; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIQUID; LUNG FUNCTION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POWDER; POWDER INHALER; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADMINISTRATION, INHALATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOGLOBULIN G; INSULIN; INSULIN ANTIBODIES; NEBULIZERS AND VAPORIZERS;

EID: 34250713861     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0207     Document Type: Conference Paper

References (38)

1. Tlaskalova-Hogenova H, Tuckova L, Lodinova-Zadnikova R, Stepankova R, Cukrowska B, Funda DP, Striz I, Kozakova H, Trebichavsky I, Sokol D, Rehakova Z, Sinkora J, Fundova P, Horakova D, Jelinkova L, Sanchez D: Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol 2002;128:77-89.
2. Poulter LW: Basic concepts in lung immunology. Res Immunol 1996;148:8-13.
3. Suarez S, Hickey AJ: Drug properties affecting aerosol behavior. Respir Care 2000;45:652-666.
4. Holt PG: Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc Am Thorac Soc 2005;2:116-120.
5. Hammad H, Lambrecht BN: Recent progress in the biology of airway dendritic cells and implications for understanding the regulation of asthmatic inflammation. J Allergy Clin Immunol 2006;118:331-336.
6. Pilette C, Ouadrhiri Y, Godding V, Vaerman J-P, Sibille Y: Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J 2001;18:571-588.
7. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K: Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996;184:2167-2174.
8. Fineberg SE: Diabetes therapy trials with inhaled insulin. Expert Opin Investig Drugs 2006;15:743-762.
9. Fineberg SE, Kawabata T, Finco-Kent D, Liu C, Krasner A: Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes: an analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. J Clin Endocrinol Metab 2005;90:3287-3294.
10. Heise T, Bott S, Tusek C, Stephan JA, Kawabata T, Finco-Kent D, Liu C, Krasner A: The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study. Diabetes Care 2005;28:2161-2169.
11. Garg S. Rosenstock J, Silverman BL, Sun B, Konkoy CS, de la Pena A, Muchmore DB: Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia 2006;49:891-899.
12. Brunner GA, Balent B, Ellmerer M, Schaupp L, Siebenhofer A, Jendle JH, Okikawa J, Pieber TR: Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients. Diabetologia 2001;44:305-308.
13. Hermansen K, Ronnemaa T, Petersen AH, Bellaire S, Adamson U: Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes. Diabetes Care 2004;27:162-167.
14. Teeter JG, Riese RJ: Dissociation of lung fuction changes with humoral immunity during inhaled human insulin therapy. Am J Respir Crit Care Med 2006;173:1194-1200.
15. Norwood P, Dumas R, Cefalu W, Yale J-F, England R, Riese R, Teeter J: Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (Exubera®). J Clin Endocrinol Metab 2006 Sep 26; [Epub ahead of print].
16. Mooradian AD, Bernbaum M, Albert SG: Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 2006;145:125-134.
17. Vajo Z, Fawcett J, Duckworth WC: Recombinant DNA technology in the treatment of diabetes: insulin analogs. Endocr Rev 2001;22:706-717.
18. Robinson DM, Wellington K: Insulin glulisine. Drugs 2006;66:861-869.
19. Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH Jr: Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes. Diabetes Care 2003;26:89-96.
20. Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R: Single cell analysis shows decreasing FoxP3 and TGF-beta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med 2005;201:1333-1346.
21. Miller RA: The aging immune system: primer and prospectus. Science 1996;273:70-74.
22. Schmucker DL, Heyworth MF, Owen RL, Daniels CK: Impact of aging on gastrointestinal mucosal immunity. Dig Dis Sci 1996;41:1183-1193.
23. McElhaney JE, Meneilly GS, Beattie BL, Helgason CD, Lee SF, Devine RD, Bleackley RC: The effect of influenza vaccination on IL2 production in healthy elderly: implications for current vaccination practices. J Gerontol 1992;47:M3-M8.
24. Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG: Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1994;78:1172-1178.
25. Van Hove CL, Maes T, Joos GF, Toumoy KG: Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol 2007;36:573-584.
26. Shkreta L, Talbot BG, Lacasse P: Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex. Vaccine 2003;21:2372-2382.
27. Robbins PF, Thomas JW, Jensen PE, Kapp JA: Insulin-specific tolerance induction. 1. Abrogation of helper T cell activity is controlled by H-2-linked lr genes. J Immunol 1984;132:43-49.
28. Jensen PE, Pierce CW, Kapp JA: Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with non-responsiveness in H-2b mice. J Exp Med 1984;160:1012-1026.
29. Lalor PA, Morahan G. The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol 1990;20:485-492.
30. Overkamp D, Mohammed-Ali S, Cartledge C, Landon J: Production of polyclonal antibodies in ascitic fluid of mice: technique and applications. J Immunoassay 1988;9:51-68.
31. Jeandidier N, Boivin S, Sapin R, Rosart-Ortega F, Uring-Lambert B, Reville P, Pinget M: Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices. Diabetologia 1995;38:577-584.
32. Olsen CL, Chan E, Turner DS, Iravani M, Nagy M, Selam JL, Wong ND, Waxman K, Charles MA: Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems. Diabetes Care 1994;17:169-176.
33. Jeandidier N, Boullu S, Busch-Brafin MS, Chabrier G, Sapin R, Gasser F, Pinget M: Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients. Diabetes Care 2002;25:84-88.
34. Fineberg SE, Galloway JA, Fineberg NS, Goldman J: Effects of species of origin, purification levels, and formulation on insulin immunogenicity. Diabetes 1983;32:592-599.
35. Fineberg SE, Galloway JA, Fineberg NS, Rathbun MJ, Hufferd S: Immunogenicity of recombinant DNA human insulin. Diabetologia 1983;25:465-469.
36. Fineberg SE, Fineberg NS, Galloway JA, Rabin BS, Fireman P, Irvine WJ: What factors regulate the immune response to insulin in type 1 and 2 diabetes? [abstract]. Diabetes 1984;33(Suppl 1):157A.
37. Fineberg SE, Fineberg NS, Estridge T, Hufford S: Long term sequelae of human vs pork vs mixed beef pork insulins in type 1 and 2 diabetes in a two year double blind clinical trial [abstract]. Diabetes 1988;37(Suppl 1):P24A.
38. Fineberg SE, Galloway JA, Fineberg NS, Rathbun MJ, Hufferd S: Immunogenicity of recombinant DNA human insulin. Diabetologia 1983;25:465-469.